chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 75.0
Sex: M
Vaccine: COVID19-2, FLUA4
Symptoms: Cellulitis, Chest X-ray normal, Constipation, Dyspnoea, Dysstasia
Clinical narrative: Discharge Provider:  Primary Care Provider: FNP Admission Date: 4/10/2023 Discharge Date: 4/14/2023   Clinical Narrative: Patient is a 76 y.o. male patient of FNP who presented 4/10/23 with traumatic wound dehiscence after falling after a recent right knee surgery.  The patient states he recently discharged home which time he was feeling quite well. He was looking forward to returning home but as he approached his home had become increasingly nauseated.  He had suffered with several bouts of vomiting.  This has not recurred and he was not quite certain as to why it happened.  He did report being severely constipated/obstipated and reports that it took a while before things began to move.  He was having abdominal cramping prior to that and improved upon having a large bowel movement.  He unfortunately reports that he fell after not feeling well.  He fell immediately after attempting to stand.  He struck his knee and suffered from wound dehiscence which required repeat surgical intervention with Dr..    During admission his blood pressure and fell requiring pressors concern for septic shock. Sepsis initially thought to be secondary to cellulitis but found to be more likely 2/2 COVID infection. He improved during his stay and was empirically treated with antibiotics. SAR was recommended; pt initially refused but reconsidered.   On day of discharge, pt mentioned feeling he is not getting full breaths of air. No CP, pleurisy or overt dyspnea. His looked comfortable, saturating 100% oxygen on room air with lungs clear and pulse in 60s. He also stated he feels like he hasn't urinated since the night before and feeling lower abdominal pressure. CXR and bladder scan were ordered. CXR was negative for any acute abnormality. PE considered but deemed unlikely on enoxaparin prophylaxis with normal heart rate and normal saturations. Bladder scan revealed 480cc pt was able to void 275 so no straight cath was indicated. Pt reported his breathing is normal after voiding.    Pt was discharged in stable condition to SAR.
Age: 75.0
Sex: M
Vaccine: COVID19-2, FLUA4
Symptoms: Fall, Injury, Joint injury, Knee operation, Malaise
Clinical narrative: Discharge Provider:  Primary Care Provider: FNP Admission Date: 4/10/2023 Discharge Date: 4/14/2023   Clinical Narrative: Patient is a 76 y.o. male patient of FNP who presented 4/10/23 with traumatic wound dehiscence after falling after a recent right knee surgery.  The patient states he recently discharged home which time he was feeling quite well. He was looking forward to returning home but as he approached his home had become increasingly nauseated.  He had suffered with several bouts of vomiting.  This has not recurred and he was not quite certain as to why it happened.  He did report being severely constipated/obstipated and reports that it took a while before things began to move.  He was having abdominal cramping prior to that and improved upon having a large bowel movement.  He unfortunately reports that he fell after not feeling well.  He fell immediately after attempting to stand.  He struck his knee and suffered from wound dehiscence which required repeat surgical intervention with Dr..    During admission his blood pressure and fell requiring pressors concern for septic shock. Sepsis initially thought to be secondary to cellulitis but found to be more likely 2/2 COVID infection. He improved during his stay and was empirically treated with antibiotics. SAR was recommended; pt initially refused but reconsidered.   On day of discharge, pt mentioned feeling he is not getting full breaths of air. No CP, pleurisy or overt dyspnea. His looked comfortable, saturating 100% oxygen on room air with lungs clear and pulse in 60s. He also stated he feels like he hasn't urinated since the night before and feeling lower abdominal pressure. CXR and bladder scan were ordered. CXR was negative for any acute abnormality. PE considered but deemed unlikely on enoxaparin prophylaxis with normal heart rate and normal saturations. Bladder scan revealed 480cc pt was able to void 275 so no straight cath was indicated. Pt reported his breathing is normal after voiding.    Pt was discharged in stable condition to SAR.
Age: 75.0
Sex: M
Vaccine: COVID19-2, FLUA4
Symptoms: Nausea, Sepsis, Surgery, Vomiting, Wound dehiscence
Clinical narrative: Discharge Provider:  Primary Care Provider: FNP Admission Date: 4/10/2023 Discharge Date: 4/14/2023   Clinical Narrative: Patient is a 76 y.o. male patient of FNP who presented 4/10/23 with traumatic wound dehiscence after falling after a recent right knee surgery.  The patient states he recently discharged home which time he was feeling quite well. He was looking forward to returning home but as he approached his home had become increasingly nauseated.  He had suffered with several bouts of vomiting.  This has not recurred and he was not quite certain as to why it happened.  He did report being severely constipated/obstipated and reports that it took a while before things began to move.  He was having abdominal cramping prior to that and improved upon having a large bowel movement.  He unfortunately reports that he fell after not feeling well.  He fell immediately after attempting to stand.  He struck his knee and suffered from wound dehiscence which required repeat surgical intervention with Dr..    During admission his blood pressure and fell requiring pressors concern for septic shock. Sepsis initially thought to be secondary to cellulitis but found to be more likely 2/2 COVID infection. He improved during his stay and was empirically treated with antibiotics. SAR was recommended; pt initially refused but reconsidered.   On day of discharge, pt mentioned feeling he is not getting full breaths of air. No CP, pleurisy or overt dyspnea. His looked comfortable, saturating 100% oxygen on room air with lungs clear and pulse in 60s. He also stated he feels like he hasn't urinated since the night before and feeling lower abdominal pressure. CXR and bladder scan were ordered. CXR was negative for any acute abnormality. PE considered but deemed unlikely on enoxaparin prophylaxis with normal heart rate and normal saturations. Bladder scan revealed 480cc pt was able to void 275 so no straight cath was indicated. Pt reported his breathing is normal after voiding.    Pt was discharged in stable condition to SAR.
Age: 61.0
Sex: M
Vaccine: COVID19-2, FLU4
Symptoms: Acute respiratory failure, Angiogram pulmonary abnormal, Atypical pneumonia, COVID-19, Chest X-ray normal
Clinical narrative: Admission Date: 4/7/2023 Discharge Date: 4/14/2023  PRESENTING PROBLEM: Acute respiratory failure with hypoxia           HOSPITAL COURSE:    Patient is a 61 y.o. male with a hx of essential hypertension, type 2 diabetes mellitus, hypothyroidism, and chronic obstructive pulmonary disease among other comorbid conditions who presented to the Emergency Department on 04/07/2023 with complaints of worsening shortness onset approx 4 days prior to presentation. On evaluation in the ER he was hemodynamically stable, afebrile, but noted to be hypoxemic, requiring 2-3 L of supplemental oxygen via nasal canula at rest. Laboratory studies were largely unremarkable but infectious work-up revealed COVID-19 infection. Imaging studies including a CXR in the ER did not reveal any acute pathology.  He was admitted to the Hospitalist Service for further management and coordination, and started on Dexamethasone therapy in addition to bronchodilator therapy and other supportive measures. On the morning of 04/09/2023 the patient's supplemental oxygen demands increased and he required 6L of supplemental O2 to maintain adequate oxygenation. As a result a CXR was obtained which did not reveal any acute changes that might explain the acute clinical decline. Though he was started on Lovenox on admission, there was concern for acute pulmonary embolism given COVID-19 infection thus a CTA thorax was ordered. Pulmonary embolus was not present but there were findings suggestive of atypical pneumonia. On 04/09/2023 he was started on Remdesivir and the pulmonology team's input was requested. They agreed with Dexamethasone and Remdesivir therapy and added community acquired pneumonia coverage as well.    61 year old with COPD and continued tobacco abuse, presented with SOB and hypoxia. Last summer had Covid and was discharged with oxygen, but never used it and had it picked up. He used a pulse-oximeter and says he was doing well and tanks would not have lasted long enough, anyway. Noted he has had markedly elevated hemoglobin 6/2022 and on this admission. He was tested for JAK 2 for polycythemia 6/2022 and was negative. It is likely secondary to chronic hypoxia. Also discussed hypercapnia with patient and wife (RN) and risk of decline with increased morbidity and mortality. He was willing to try again overnight and have a Bipap at home.      During hospitalization he was noted to have increased hypercarbia and was trialed on Bipap. 4/12/2023 night he refused after 2 hours. Following night he tried longer and willing to use this and oxygen at home. Also willing to try and quit smoking. Reviewing his hemoglobin elevation it is indicative of chronic hypoxia.
Age: 61.0
Sex: M
Vaccine: COVID19-2, FLU4
Symptoms: Chronic obstructive pulmonary disease, Condition aggravated, Dyspnoea, Haemoglobin abnormal, Hypercapnia
Clinical narrative: Admission Date: 4/7/2023 Discharge Date: 4/14/2023  PRESENTING PROBLEM: Acute respiratory failure with hypoxia           HOSPITAL COURSE:    Patient is a 61 y.o. male with a hx of essential hypertension, type 2 diabetes mellitus, hypothyroidism, and chronic obstructive pulmonary disease among other comorbid conditions who presented to the Emergency Department on 04/07/2023 with complaints of worsening shortness onset approx 4 days prior to presentation. On evaluation in the ER he was hemodynamically stable, afebrile, but noted to be hypoxemic, requiring 2-3 L of supplemental oxygen via nasal canula at rest. Laboratory studies were largely unremarkable but infectious work-up revealed COVID-19 infection. Imaging studies including a CXR in the ER did not reveal any acute pathology.  He was admitted to the Hospitalist Service for further management and coordination, and started on Dexamethasone therapy in addition to bronchodilator therapy and other supportive measures. On the morning of 04/09/2023 the patient's supplemental oxygen demands increased and he required 6L of supplemental O2 to maintain adequate oxygenation. As a result a CXR was obtained which did not reveal any acute changes that might explain the acute clinical decline. Though he was started on Lovenox on admission, there was concern for acute pulmonary embolism given COVID-19 infection thus a CTA thorax was ordered. Pulmonary embolus was not present but there were findings suggestive of atypical pneumonia. On 04/09/2023 he was started on Remdesivir and the pulmonology team's input was requested. They agreed with Dexamethasone and Remdesivir therapy and added community acquired pneumonia coverage as well.    61 year old with COPD and continued tobacco abuse, presented with SOB and hypoxia. Last summer had Covid and was discharged with oxygen, but never used it and had it picked up. He used a pulse-oximeter and says he was doing well and tanks would not have lasted long enough, anyway. Noted he has had markedly elevated hemoglobin 6/2022 and on this admission. He was tested for JAK 2 for polycythemia 6/2022 and was negative. It is likely secondary to chronic hypoxia. Also discussed hypercapnia with patient and wife (RN) and risk of decline with increased morbidity and mortality. He was willing to try again overnight and have a Bipap at home.      During hospitalization he was noted to have increased hypercarbia and was trialed on Bipap. 4/12/2023 night he refused after 2 hours. Following night he tried longer and willing to use this and oxygen at home. Also willing to try and quit smoking. Reviewing his hemoglobin elevation it is indicative of chronic hypoxia.
Age: 61.0
Sex: M
Vaccine: COVID19-2, FLU4
Symptoms: Hypoxia, Oxygen saturation decreased, Pneumonia, Positive airway pressure therapy, SARS-CoV-2 test positive
Clinical narrative: Admission Date: 4/7/2023 Discharge Date: 4/14/2023  PRESENTING PROBLEM: Acute respiratory failure with hypoxia           HOSPITAL COURSE:    Patient is a 61 y.o. male with a hx of essential hypertension, type 2 diabetes mellitus, hypothyroidism, and chronic obstructive pulmonary disease among other comorbid conditions who presented to the Emergency Department on 04/07/2023 with complaints of worsening shortness onset approx 4 days prior to presentation. On evaluation in the ER he was hemodynamically stable, afebrile, but noted to be hypoxemic, requiring 2-3 L of supplemental oxygen via nasal canula at rest. Laboratory studies were largely unremarkable but infectious work-up revealed COVID-19 infection. Imaging studies including a CXR in the ER did not reveal any acute pathology.  He was admitted to the Hospitalist Service for further management and coordination, and started on Dexamethasone therapy in addition to bronchodilator therapy and other supportive measures. On the morning of 04/09/2023 the patient's supplemental oxygen demands increased and he required 6L of supplemental O2 to maintain adequate oxygenation. As a result a CXR was obtained which did not reveal any acute changes that might explain the acute clinical decline. Though he was started on Lovenox on admission, there was concern for acute pulmonary embolism given COVID-19 infection thus a CTA thorax was ordered. Pulmonary embolus was not present but there were findings suggestive of atypical pneumonia. On 04/09/2023 he was started on Remdesivir and the pulmonology team's input was requested. They agreed with Dexamethasone and Remdesivir therapy and added community acquired pneumonia coverage as well.    61 year old with COPD and continued tobacco abuse, presented with SOB and hypoxia. Last summer had Covid and was discharged with oxygen, but never used it and had it picked up. He used a pulse-oximeter and says he was doing well and tanks would not have lasted long enough, anyway. Noted he has had markedly elevated hemoglobin 6/2022 and on this admission. He was tested for JAK 2 for polycythemia 6/2022 and was negative. It is likely secondary to chronic hypoxia. Also discussed hypercapnia with patient and wife (RN) and risk of decline with increased morbidity and mortality. He was willing to try again overnight and have a Bipap at home.      During hospitalization he was noted to have increased hypercarbia and was trialed on Bipap. 4/12/2023 night he refused after 2 hours. Following night he tried longer and willing to use this and oxygen at home. Also willing to try and quit smoking. Reviewing his hemoglobin elevation it is indicative of chronic hypoxia.
Age: 45.0
Sex: F
Vaccine: FLUR4
Symptoms: Chest pain, Cough, Malaise, Mobility decreased, Nasal congestion
Clinical narrative: On 12/27 cough onset, uncontrollable cough with chest pain, wheezing began a couple of days later, I started albuterol after a phone consult with an doctor. Months later I am still sick, still coughing uncontrollably, using albuterol and have started anoro elipta in April. I see a lung doctor this month. Chest pain in side chest is nearly unbearable and I can hardly lean over or lean sideways. I also have congestion, nasal blockage and ent was unable to laryngoscope, ordered a CT scan but I cannot do that scan because I cannot lie flat on my back without coughing until I nearly throw up.
Age: 45.0
Sex: F
Vaccine: FLUR4
Symptoms: Respiratory tract congestion, Sinonasal obstruction, Wheezing
Clinical narrative: On 12/27 cough onset, uncontrollable cough with chest pain, wheezing began a couple of days later, I started albuterol after a phone consult with an doctor. Months later I am still sick, still coughing uncontrollably, using albuterol and have started anoro elipta in April. I see a lung doctor this month. Chest pain in side chest is nearly unbearable and I can hardly lean over or lean sideways. I also have congestion, nasal blockage and ent was unable to laryngoscope, ordered a CT scan but I cannot do that scan because I cannot lie flat on my back without coughing until I nearly throw up.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Deep vein thrombosis
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE ACUTE DVT, UNSPECIFIED VEIN
Age: 56.0
Sex: F
Vaccine: VARZOS
Symptoms: Hypotension, Lethargy, Rash erythematous, Rash pruritic
Clinical narrative: itchy red bumps, low blood pressure, lethargy
Age: 0.5
Sex: M
Vaccine: COVID19-2
Symptoms: No adverse event, Wrong product administered
Clinical narrative: There is no adverse event but this is considered a vaccine administration error due to the lack of information given to us when the dosing changed with the removal of the monovalent vaccine. We did not receive any updated dosing instructions until this week which did not give clear or apparent directions involving change in vials and age indications. There should have been a complete halt in vaccinating until clear and concise instructions were made available to the healthcare industry. Clear and concise does not mean sifting through 72 pages and clicking on multiple links to find the needle in the haystack.  Now we have a vaccination error due to the lack of information from those in charge who dropped the ball. We take no fault in this error. This patient should have received the blue cap gray label bivalent but received the yellow label pink top bivalent. (who uses these descriptions to clearly instruct people on what to do?) This is unsafe and unclear. You also assume that we have knowledge of all the vials and different formulations out there when we don't. You totally dropped the ball and this error rests on those who make the rules and instructions. Parents dont have faith in vaccines anymore and this error does not help.
Age: 74.0
Sex: M
Vaccine: COVID19-2
Symptoms: Acute myocardial infarction, Anticoagulant therapy, Atrial fibrillation, COVID-19, Cardiogenic shock
Clinical narrative: Discharge Provider: MD Primary Care Provider: MD Admission Date: 4/5/2023 Discharge Date: 4/10/23   PRESENTING PROBLEM: Acute on chronic respiratory failure [J96.20] Acute respiratory failure with hypoxia [J96.01] Tracheostomy complication, unspecified complication type [J95.00] Acute on chronic respiratory failure with hypoxia [J96.21]   HOSPITAL COURSE: 74-year-old male with complex medical history including AFib, ulcerative colitis, CVA, PE/DVT, and coronary artery disease who was admitted to the intensive care unit from LTACH on 04/05/2023 after having worsening hypoxemia and secretions.  The patient was admitted in January, 2023 to hospital for rectal bleeding.  The patient was also found to have inferior wall STEMI complicated by cardiogenic shock and respiratory failure requiring intubation/extubation, pneumonia, PE and DVT.  The patient was transferred to Hospital for IVC filter placement as he had GI bleeding with heparin drip.  The patient was transferred rehab and then was admitted to different Hospital on 02/21/2023 for fecal impaction and was found to have stroke.  The patient was then discharged to inpatient rehab on 02/24/2023.  At the rehab the patient was found to have AFib with RVR and was transferred back to Hospital.  The patient developed VT arrest requiring CPR and intubation.  He was found to have severe multivessel disease not amenable for PCI/CABG on 03/03/2023.  Trach was placed on 03/22/2023 and the patient was transferred to LTACH on 03/27/2023 for trach management.  At LTACH, on 04/04/2023 trach was decannulated.  However on 04/05/2023, the patient had worsening hypoxemia and secretions.  The patient was also found to have COVID 19. The patient was admitted to the intensive care unit for trach replacement.  ENT was consulted and replace trach.  The patient was given remdesivir and Decadron for COVID 19 infection. The patient needs a 3 day critical airway watch prior to return to LTACH. Cardiology was consulted.  The patient was transferred out of the intensive care unit to the hospitalist service on 04/06/2023. He had a trach exchange again to smaller size on 4/7 by pulmonology team. He did well after this. Seen by SLP who again recommended strict NPO and tried speaking valve but stated not currently ready for speaking valve during eval. He was discharged to acute rehab in stable conditions.
Age: 74.0
Sex: M
Vaccine: COVID19-2
Symptoms: Cerebrovascular accident, Coronary artery disease, Deep vein thrombosis, Endotracheal intubation, Faecaloma
Clinical narrative: Discharge Provider: MD Primary Care Provider: MD Admission Date: 4/5/2023 Discharge Date: 4/10/23   PRESENTING PROBLEM: Acute on chronic respiratory failure [J96.20] Acute respiratory failure with hypoxia [J96.01] Tracheostomy complication, unspecified complication type [J95.00] Acute on chronic respiratory failure with hypoxia [J96.21]   HOSPITAL COURSE: 74-year-old male with complex medical history including AFib, ulcerative colitis, CVA, PE/DVT, and coronary artery disease who was admitted to the intensive care unit from LTACH on 04/05/2023 after having worsening hypoxemia and secretions.  The patient was admitted in January, 2023 to hospital for rectal bleeding.  The patient was also found to have inferior wall STEMI complicated by cardiogenic shock and respiratory failure requiring intubation/extubation, pneumonia, PE and DVT.  The patient was transferred to Hospital for IVC filter placement as he had GI bleeding with heparin drip.  The patient was transferred rehab and then was admitted to different Hospital on 02/21/2023 for fecal impaction and was found to have stroke.  The patient was then discharged to inpatient rehab on 02/24/2023.  At the rehab the patient was found to have AFib with RVR and was transferred back to Hospital.  The patient developed VT arrest requiring CPR and intubation.  He was found to have severe multivessel disease not amenable for PCI/CABG on 03/03/2023.  Trach was placed on 03/22/2023 and the patient was transferred to LTACH on 03/27/2023 for trach management.  At LTACH, on 04/04/2023 trach was decannulated.  However on 04/05/2023, the patient had worsening hypoxemia and secretions.  The patient was also found to have COVID 19. The patient was admitted to the intensive care unit for trach replacement.  ENT was consulted and replace trach.  The patient was given remdesivir and Decadron for COVID 19 infection. The patient needs a 3 day critical airway watch prior to return to LTACH. Cardiology was consulted.  The patient was transferred out of the intensive care unit to the hospitalist service on 04/06/2023. He had a trach exchange again to smaller size on 4/7 by pulmonology team. He did well after this. Seen by SLP who again recommended strict NPO and tried speaking valve but stated not currently ready for speaking valve during eval. He was discharged to acute rehab in stable conditions.
Age: 74.0
Sex: M
Vaccine: COVID19-2
Symptoms: Hypoxia, Intensive care, Pneumonia, Rectal haemorrhage, Respiratory failure
Clinical narrative: Discharge Provider: MD Primary Care Provider: MD Admission Date: 4/5/2023 Discharge Date: 4/10/23   PRESENTING PROBLEM: Acute on chronic respiratory failure [J96.20] Acute respiratory failure with hypoxia [J96.01] Tracheostomy complication, unspecified complication type [J95.00] Acute on chronic respiratory failure with hypoxia [J96.21]   HOSPITAL COURSE: 74-year-old male with complex medical history including AFib, ulcerative colitis, CVA, PE/DVT, and coronary artery disease who was admitted to the intensive care unit from LTACH on 04/05/2023 after having worsening hypoxemia and secretions.  The patient was admitted in January, 2023 to hospital for rectal bleeding.  The patient was also found to have inferior wall STEMI complicated by cardiogenic shock and respiratory failure requiring intubation/extubation, pneumonia, PE and DVT.  The patient was transferred to Hospital for IVC filter placement as he had GI bleeding with heparin drip.  The patient was transferred rehab and then was admitted to different Hospital on 02/21/2023 for fecal impaction and was found to have stroke.  The patient was then discharged to inpatient rehab on 02/24/2023.  At the rehab the patient was found to have AFib with RVR and was transferred back to Hospital.  The patient developed VT arrest requiring CPR and intubation.  He was found to have severe multivessel disease not amenable for PCI/CABG on 03/03/2023.  Trach was placed on 03/22/2023 and the patient was transferred to LTACH on 03/27/2023 for trach management.  At LTACH, on 04/04/2023 trach was decannulated.  However on 04/05/2023, the patient had worsening hypoxemia and secretions.  The patient was also found to have COVID 19. The patient was admitted to the intensive care unit for trach replacement.  ENT was consulted and replace trach.  The patient was given remdesivir and Decadron for COVID 19 infection. The patient needs a 3 day critical airway watch prior to return to LTACH. Cardiology was consulted.  The patient was transferred out of the intensive care unit to the hospitalist service on 04/06/2023. He had a trach exchange again to smaller size on 4/7 by pulmonology team. He did well after this. Seen by SLP who again recommended strict NPO and tried speaking valve but stated not currently ready for speaking valve during eval. He was discharged to acute rehab in stable conditions.
Age: 74.0
Sex: M
Vaccine: COVID19-2
Symptoms: Resuscitation, Secretion discharge, Tracheostomy, Vena cava filter insertion, Ventricular tachycardia
Clinical narrative: Discharge Provider: MD Primary Care Provider: MD Admission Date: 4/5/2023 Discharge Date: 4/10/23   PRESENTING PROBLEM: Acute on chronic respiratory failure [J96.20] Acute respiratory failure with hypoxia [J96.01] Tracheostomy complication, unspecified complication type [J95.00] Acute on chronic respiratory failure with hypoxia [J96.21]   HOSPITAL COURSE: 74-year-old male with complex medical history including AFib, ulcerative colitis, CVA, PE/DVT, and coronary artery disease who was admitted to the intensive care unit from LTACH on 04/05/2023 after having worsening hypoxemia and secretions.  The patient was admitted in January, 2023 to hospital for rectal bleeding.  The patient was also found to have inferior wall STEMI complicated by cardiogenic shock and respiratory failure requiring intubation/extubation, pneumonia, PE and DVT.  The patient was transferred to Hospital for IVC filter placement as he had GI bleeding with heparin drip.  The patient was transferred rehab and then was admitted to different Hospital on 02/21/2023 for fecal impaction and was found to have stroke.  The patient was then discharged to inpatient rehab on 02/24/2023.  At the rehab the patient was found to have AFib with RVR and was transferred back to Hospital.  The patient developed VT arrest requiring CPR and intubation.  He was found to have severe multivessel disease not amenable for PCI/CABG on 03/03/2023.  Trach was placed on 03/22/2023 and the patient was transferred to LTACH on 03/27/2023 for trach management.  At LTACH, on 04/04/2023 trach was decannulated.  However on 04/05/2023, the patient had worsening hypoxemia and secretions.  The patient was also found to have COVID 19. The patient was admitted to the intensive care unit for trach replacement.  ENT was consulted and replace trach.  The patient was given remdesivir and Decadron for COVID 19 infection. The patient needs a 3 day critical airway watch prior to return to LTACH. Cardiology was consulted.  The patient was transferred out of the intensive care unit to the hospitalist service on 04/06/2023. He had a trach exchange again to smaller size on 4/7 by pulmonology team. He did well after this. Seen by SLP who again recommended strict NPO and tried speaking valve but stated not currently ready for speaking valve during eval. He was discharged to acute rehab in stable conditions.
Age: 5.0
Sex: F
Vaccine: COVID19-2
Symptoms: Erythema, Pain in extremity, Pruritus
Clinical narrative: Red patches on legs. They are painful and itchy
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Computerised tomogram abnormal, Echocardiogram abnormal, Electrocardiogram abnormal, Pericarditis
Clinical narrative: Chest pain.  Hospitalized with Pericarditis on 4/11/23 thru 4/19/23.
Age: 4.0
Sex: F
Vaccine: COVID19-2
Symptoms: Wrong product administered
Clinical narrative: THERE IS NO ADVERSE EVENT BUT THIS IS CONSIDERED A VACCINE ADMINISTRATION ERROR DUE TO THE LACK OF INFORMATION GIVEN TO US WHEN THE DOSING CHANGED WITH THE REMOVAL OF THE MONOVALENT VACCINE. WE DID NOT RECEIVE ANY UPDATED DOSING INSTRUCTIONS UNTIL THIS WEEK WHICH DID NOT GIVE CLEAR OR APPARENT DIRECTIONS INVOLVING CHANGE IN VIALS AND AGE INDICATIONS. THERE SHOULD HAVE BEEN A COMPLETE HALT IN VACCINATING UNTIL CLEAR AND CONCISE INSTRUCTIONS WERE MADE AVAILABLE TO THE HEALTHCARE INDUSTRY. CLEAR AND CONCISE DOES NOT MEAN SIFTING THROUGH 72 PAGES AND CLICKING ON MULTIPLE LINKS TO FIND THE NEEDLE IN THE HAYSTACK.  NOW WE HAVE A VACCINATION ERROR DUE TO THE LACK OF INFORMATION FROM THOSE IN CHARGE WHO DROPPED THE BALL. WE TAKE NO FAULT IN THIS ERROR. THIS PATIENT SHOULD HAVE RECEIVED THE BLUE CAP GRAY LABEL BIVALENT BUT RECEIVED THE YELLOW LABEL PINK TOP BIVALENT. (WHO USES THESE DESCRIPTIONS TO CLEARLY INSTRUCT PEOPLE ON WHAT TO DO?) THIS IS UNSAFE AND UNCLEAR. YOU ALSO ASSUME THAT WE HAVE KNOWLEDGE OF ALL THE VIALS AND DIFFERENT FORMULATIONS OUT THERE WHEN WE DON'T. YOU TOTALLY DROPPED THE BALL AND THIS ERROR RESTS ON THOSE WHO MAKE THE RULES AND INSTRUCTIONS.
Age: 61.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, Cough, Fatigue, Headache, Myalgia
Clinical narrative: I was positive for COVID-19 on 10DEC2023, I was experiencing severe headache, fever, chest congestion and cough. I also, had sinus infection and I was very tired and muscle ache. I spoke to my doctor and he prescribed me molnupiravir, I could take PAXLOVID because of my health issues.
Age: 61.0
Sex: F
Vaccine: COVID19-2
Symptoms: Pyrexia, Respiratory tract congestion, SARS-CoV-2 test positive, Sinusitis
Clinical narrative: I was positive for COVID-19 on 10DEC2023, I was experiencing severe headache, fever, chest congestion and cough. I also, had sinus infection and I was very tired and muscle ache. I spoke to my doctor and he prescribed me molnupiravir, I could take PAXLOVID because of my health issues.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Cerebrovascular accident
Clinical narrative: ACUTE STROKE, UNSPECIFIED TYPE AND ARTERY
Age: 60.0
Sex: M
Vaccine: COVID19-2
Symptoms: Anxiety, Diarrhoea, Dry mouth, Rhinorrhoea
Clinical narrative: sniffles, diarrhea, anxiety, dry mouth
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Hypoxia, Symptom recurrence
Clinical narrative: ACUTE HYPOXEMIC RESPIRATORY FAILURE HYPOXEMIA 6/17/2022,  7/24/2022,  10/19/2022  -- RECURRENCE OF SAME SYMPTOMS
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Ankle fracture, Hypoxia, Joint dislocation, Obstructive sleep apnoea syndrome, Sleep apnoea syndrome
Clinical narrative: Pfizer vaccine was administered outside of our facility - reported by patient- ? NO LOT NUMBER WERE SUPPLIED ---------------------------------------------------------------------------------------------------------------------- G47.33 OBSTRUCTIVE SLEEP APNEA 11/30/2021 HYPOXIA R09.02 HYPOXIA 11/30/2021 HYPOXIA G47.33 OBSTRUCTIVE SLEEP APNEA 11/30/2021 LEFT ANKLE FX ROUT SUBSEQ R09.02 HYPOXIA 11/30/2021 LEFT ANKLE FX ROUT SUBSEQ G47.33 OBSTRUCTIVE SLEEP APNEA 11/30/2021 LEFT BIMALLEOLAR FX DISPL ROUT SUBSEQ R09.02 HYPOXIA 11/30/2021 LEFT BIMALLEOLAR FX DISPL ROUT SUBSEQ G47.33 OBSTRUCTIVE SLEEP APNEA 11/30/2021 OPEN LEFT ANKLE DISLOCATION, INIT R09.02 HYPOXIA 11/30/2021 OPEN LEFT ANKLE DISLOCATION, INIT G47.33 OBSTRUCTIVE SLEEP APNEA 11/30/2021 HYPOXIA R09.02 HYPOXIA 11/30/2021 HYPOXIA
Age: 90.0
Sex: M
Vaccine: COVID19-2
Symptoms: Cough, Laboratory test abnormal, Pneumonia
Clinical narrative: I did not have an adverse reaction to the vaccine. In 12/2022, I was diagnosed with pneumonia. I saw my doctor but I only remember taking MUCINEX for the cough.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Hyperlipidaemia
Clinical narrative: J96.00 ACUTE RESPIRATORY FAILURE 5/20/2022 HYPERLIPIDEMIA
Age: 6.0
Sex: M
Vaccine: TD
Symptoms: Aggression, Cognitive disorder
Clinical narrative: Pt. is more aggressive and impulsive than pre-injection condition. He also has less cognitive focus as compared to pre-injection condition. Additionally, Item 21 Response is for current 72 hours only. Item 21 Response is subject to change.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Asthma, Status epilepticus
Clinical narrative: G40.901 STATUS EPILEPTICUS 2/28/2022 ASTHMA, UNSPECIFIED J96.00 ACUTE RESPIRATORY FAILURE 11/29/2021 ASTHMA, UNSPECIFIED J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 2/28/2022 ASTHMA, UNSPECIFIED G40.901 STATUS EPILEPTICUS 2/28/2022 ASTHMA, UNSPECIFIED J96.00 ACUTE RESPIRATORY FAILURE 11/29/2021 ASTHMA, UNSPECIFIED J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 2/28/2022 ASTHMA, UNSPECIFIED
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Acoustic stimulation tests abnormal, Deafness, Tinnitus
Clinical narrative: Tinnitus continuous sound - Since date of 3rd of 4 Covid shots on 4-7-2022.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: ADMINISTERED EXPIRED VACCINE FROM 4/30/2023
Age: 62.0
Sex: M
Vaccine: SMALLMNK
Symptoms: Thrombosis
Clinical narrative: Blood Clot- unsure of where
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoxia
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE HYPOXIA
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Decubitus ulcer, Hyperglycaemia, Idiopathic pulmonary fibrosis, Type 2 diabetes mellitus
Clinical narrative: vaccine was administered outside of Facility- reported by patient ? NO LOT NUMBER WERE SUPPLIED --------------------------------------------------------------------------------------------------------------------------- J96.00 ACUTE RESPIRATORY FAILURE 11/23/2021 DM 2 W HYPERGLYCEMIA J96.00 ACUTE RESPIRATORY FAILURE 11/23/2021 IDIOPATHIC PULMONARY FIBROSIS J96.00 ACUTE RESPIRATORY FAILURE 11/23/2021 PRESSURE ULCER OF BUTTOCK, UNSPECIFIED SIDE AND STAGE J96.00 ACUTE RESPIRATORY FAILURE 11/23/2021 DM 2 W HYPERGLYCEMIA
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, Dyspnoea, Fatigue, Headache
Clinical narrative: I experienced a breakthrough case of COVID-19 with general fatigue, headaches, breathing difficulty, shortness of breath and cough.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: I experienced a breakthrough case of COVID-19 with general fatigue, headaches, breathing difficulty, shortness of breath and cough.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Facial paresis
Clinical narrative: LEFT FACIAL MUSCLE WEAKNESS
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Computerised tomogram, Ultrasound bladder, Urinary tract infection
Clinical narrative: I had a UTI in October then another one in December.  I received antibiotics both times.  I had UTI's  each time I've received a vaccine. Since sept of 2022, I've had one every month. I believe I've had 9 total.  I've also visited a urologist since having these reoccurring  UTI's.
Age: 83.0
Sex: M
Vaccine: COVID19-2
Symptoms: Computerised tomogram abnormal, Swelling
Clinical narrative: I went out on Monday at the shooting range. On Tuesday my left side, I started experiencing some swelling, I had put ice packs on it. On Wednesday I went to the emergency room, they did a CAT scan that showed extreme swelling. I was given an antibiotic to help with possible infection. I have a follow up visit with my ENT and a needle biopsy.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Acute kidney injury, Coronary artery disease, Hypotension, Metabolic encephalopathy
Clinical narrative: Pfizer vaccine was administered outside of our facility - reported by patient- ? NO LOT NUMBER WERE SUPPLIED --------------------------------------------------------------------------------------------------------------------------- I95.9 HYPOTENSION 7/29/2021 ACUTE RENAL FAILURE, UNSPECIFIED I95.9 HYPOTENSION 7/29/2021 CAD (CORONARY ARTERY DISEASE) WO ANGINA I95.9 HYPOTENSION 7/29/2021 CAD (CORONARY ARTERY DISEASE) WO ANGINA I95.9 HYPOTENSION 7/29/2021 METABOLIC ENCEPHALOPATHY
Age: 90.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure
Clinical narrative: ACUTE HYPOXEMIC RESPIRATORY FAILURE
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE
Age: 63.0
Sex: F
Vaccine: VARZOS
Symptoms: Chills, Pruritus, Pyrexia, Rash
Clinical narrative: CHILLS RASH ON LOWER EXTREMITIES ITCHING FEVER
Age: 64.0
Sex: M
Vaccine: FLUA4
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Patient was 64 years old at the time of vaccination; however, he received FluAd, which is indicated for 65 years and older, by error.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: ADMINISTRATION OF EXPIRED NOVAVAX OF 4.30.23
Age: 0.5
Sex: F
Vaccine: COVID19-2, DTAPIPVHIB, PNC13, RV5
Symptoms: Underdose
Clinical narrative: Moderna Bivalent pediatric 0.2ml was given instead of new guidlines of Moderna Bivalent adult  .25ml.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Death, SARS-CoV-2 test positive
Clinical narrative: Patient tested positive for COVID-19 on April 21, 2023, patient expired on May 1, 2023.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Cerebrovascular accident
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE ACUTE STROKE, UNSPECIFIED TYPE AND ARTERY
Age: 30.0
Sex: F
Vaccine: PNC20
Symptoms: Erythema, Pain, Swelling
Clinical narrative: Redness, Swelling, Pain  Hydrocortisone Cream, Oral and Topical Benadryl, Ice Applications
Age: 15.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: ADMINISTRATION OF EXPIRED VACCINE 4/30/23.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Embolic stroke, Embolism arterial
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE ACUTE STROKE DUE TO EMBOLISM OF UNSPECIFIED ARTERY
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: ADMINISTRATION OF EXPIRED VACCINE 4/30/23.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Hypersensitivity
Clinical narrative: ALLERGIC REACTION, INIT
Age: 4.0
Sex: F
Vaccine: COVID19
Symptoms: Circumstance or information capable of leading to medication error, No adverse event, Product administered to patient of inappropriate age
Clinical narrative: This patient as brought in to the clinic at the time when Pfizer vaccine was just authorized for 5 years and up. The father that brought the patient in filled out the forms required at the time for the vaccine. The date on the form was put down on the form to present the patient as a 5 year old. The parent signed the form attessting that all information was correct including the date of birth. Which I got a verbal confirmation from the parent. Sometime after that it was found out that the information given to us by the parent was incorrect regarding the DOB at the time the vaccination was to be intered in system. Parents were attempted to be reached and we were not able to make contact. The patient was monitered post vaccination for the required 15 minutes and did not exibit any adverse reactions,symptoms or complaints. The patient left ambulatory with the parent.
Age: 46.0
Sex: F
Vaccine: COVID19-2
Symptoms: Alopecia, Condition aggravated, Depression, Dysgraphia, Herpes zoster
Clinical narrative: After dose 4 I began to have symptoms of shingles and then developed shingles a second time three weeks later.  I had a tiny patch of rosacea under my chin that exploded all over my face.  I saw a dermatologist for this and have received medication.  I do have scarring from this.  I began to lose my hair and lost over half of my hair.  I am no longer losing hair at this time. My migraines became much worse and will get treatment for them soon.  The tremor in my hands became so much worse that I am no longer able to write on some days.  My depression symptoms have gotten worse.  I also had geographic tongue and candida.
Age: 46.0
Sex: F
Vaccine: COVID19-2
Symptoms: Migraine, Rosacea, Scar, Skin candida, Tongue geographic
Clinical narrative: After dose 4 I began to have symptoms of shingles and then developed shingles a second time three weeks later.  I had a tiny patch of rosacea under my chin that exploded all over my face.  I saw a dermatologist for this and have received medication.  I do have scarring from this.  I began to lose my hair and lost over half of my hair.  I am no longer losing hair at this time. My migraines became much worse and will get treatment for them soon.  The tremor in my hands became so much worse that I am no longer able to write on some days.  My depression symptoms have gotten worse.  I also had geographic tongue and candida.
Age: 46.0
Sex: F
Vaccine: COVID19-2
Symptoms: Tremor
Clinical narrative: After dose 4 I began to have symptoms of shingles and then developed shingles a second time three weeks later.  I had a tiny patch of rosacea under my chin that exploded all over my face.  I saw a dermatologist for this and have received medication.  I do have scarring from this.  I began to lose my hair and lost over half of my hair.  I am no longer losing hair at this time. My migraines became much worse and will get treatment for them soon.  The tremor in my hands became so much worse that I am no longer able to write on some days.  My depression symptoms have gotten worse.  I also had geographic tongue and candida.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Chronic respiratory failure, Hypoxia, Pulmonary embolism, Respiratory failure
Clinical narrative: ACUTE RESPIRATORY FAILURE ACUTE PULMONARY EMBOLISM CHRONIC HYPOXEMIC RESPIRATORY FAILURE HYPOXIA
Age: 74.0
Sex: F
Vaccine: COVID19-2
Symptoms: Anticoagulant therapy, Atrial fibrillation, Echocardiogram abnormal, Electrocardiogram abnormal
Clinical narrative: Developed AFIB- on Eliquis
Age: 18.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: ADMINISTRATION OF EXPIRED VACCINE 4/30/23
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Chronic obstructive pulmonary disease, Chronic respiratory failure, Condition aggravated, Hypoxia
Clinical narrative: Moderna vaccine was administered outside of office - reported by patient ? NO LOT NUMBER WERE SUPPLIED ------------------------------------------------------------------------------------------------------------------------------- J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 7/16/2022 ACUTE EXACERBATION OF COPD J96.12 CHRONIC HYPERCAPNIC RESPIRATORY FAILURE 7/16/2022 ACUTE EXACERBATION OF COPD J96.90 RESPIRATORY FAILURE, UNSPECIFIED ACUITY 8/28/2022 ACUTE EXACERBATION OF COPD R09.02 HYPOXIA 6/22/2022 ACUTE EXACERBATION OF COPD J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 7/16/2022 COPD (CHRONIC OBSTRUCTIVE PULMONARY DISEASE) J96.12 CHRONIC HYPERCAPNIC RESPIRATORY FAILURE 7/16/2022 COPD (CHRONIC OBSTRUCTIVE PULMONARY DISEASE) J96.90 RESPIRATORY FAILURE, UNSPECIFIED ACUITY 8/28/2022 COPD (CHRONIC OBSTRUCTIVE PULMONARY DISEASE) R09.02 HYPOXIA 6/22/2022 COPD (CHRONIC OBSTRUCTIVE PULMONARY DISEASE) J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 7/16/2022 COPD (CHRONIC OBSTRUCTIVE PULMONARY DISEASE) J96.12 CHRONIC HYPERCAPNIC RESPIRATORY FAILURE 7/16/2022 COPD (CHRONIC OBSTRUCTIVE PULMONARY DISEASE) J96.90 RESPIRATORY FAILURE, UNSPECIFIED ACUITY 8/28/2022 COPD (CHRONIC OBSTRUCTIVE PULMONARY DISEASE) R09.02 HYPOXIA 6/22/2022 COPD (CHRONIC OBSTRUCTIVE PULMONARY DISEASE) J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 7/16/2022 ACUTE HYPOXEMIC RESPIRATORY FAILURE J96.12 CHRONIC HYPERCAPNIC RESPIRATORY FAILURE 7/16/2022 ACUTE HYPOXEMIC RESPIRATORY FAILURE J96.90 RESPIRATORY FAILURE, UNSPECIFIED ACUITY 8/28/2022 ACUTE HYPOXEMIC RESPIRATORY FAILURE R09.02 HYPOXIA 6/22/2022 ACUTE HYPOXEMIC RESPIRATORY FAILURE J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 7/16/2022 ACUTE EXACERBATION OF COPD J96.12 CHRONIC HYPERCAPNIC RESPIRATORY FAILURE 7/16/2022 ACUTE EXACERBATION OF COPD J96.90 RESPIRATORY FAILURE, UNSPECIFIED ACUITY 8/28/2022 ACUTE EXACERBATION OF COPD R09.02 HYPOXIA 6/22/2022 ACUTE EXACERBATION OF COPD
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Respiratory failure
Clinical narrative: Moderna vaccine was administered outside of office - reported by patient ? NO LOT NUMBER WERE SUPPLIED ------------------------------------------------------------------------------------------------------------------------------- J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 7/16/2022 ACUTE EXACERBATION OF COPD J96.12 CHRONIC HYPERCAPNIC RESPIRATORY FAILURE 7/16/2022 ACUTE EXACERBATION OF COPD J96.90 RESPIRATORY FAILURE, UNSPECIFIED ACUITY 8/28/2022 ACUTE EXACERBATION OF COPD R09.02 HYPOXIA 6/22/2022 ACUTE EXACERBATION OF COPD J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 7/16/2022 COPD (CHRONIC OBSTRUCTIVE PULMONARY DISEASE) J96.12 CHRONIC HYPERCAPNIC RESPIRATORY FAILURE 7/16/2022 COPD (CHRONIC OBSTRUCTIVE PULMONARY DISEASE) J96.90 RESPIRATORY FAILURE, UNSPECIFIED ACUITY 8/28/2022 COPD (CHRONIC OBSTRUCTIVE PULMONARY DISEASE) R09.02 HYPOXIA 6/22/2022 COPD (CHRONIC OBSTRUCTIVE PULMONARY DISEASE) J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 7/16/2022 COPD (CHRONIC OBSTRUCTIVE PULMONARY DISEASE) J96.12 CHRONIC HYPERCAPNIC RESPIRATORY FAILURE 7/16/2022 COPD (CHRONIC OBSTRUCTIVE PULMONARY DISEASE) J96.90 RESPIRATORY FAILURE, UNSPECIFIED ACUITY 8/28/2022 COPD (CHRONIC OBSTRUCTIVE PULMONARY DISEASE) R09.02 HYPOXIA 6/22/2022 COPD (CHRONIC OBSTRUCTIVE PULMONARY DISEASE) J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 7/16/2022 ACUTE HYPOXEMIC RESPIRATORY FAILURE J96.12 CHRONIC HYPERCAPNIC RESPIRATORY FAILURE 7/16/2022 ACUTE HYPOXEMIC RESPIRATORY FAILURE J96.90 RESPIRATORY FAILURE, UNSPECIFIED ACUITY 8/28/2022 ACUTE HYPOXEMIC RESPIRATORY FAILURE R09.02 HYPOXIA 6/22/2022 ACUTE HYPOXEMIC RESPIRATORY FAILURE J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 7/16/2022 ACUTE EXACERBATION OF COPD J96.12 CHRONIC HYPERCAPNIC RESPIRATORY FAILURE 7/16/2022 ACUTE EXACERBATION OF COPD J96.90 RESPIRATORY FAILURE, UNSPECIFIED ACUITY 8/28/2022 ACUTE EXACERBATION OF COPD R09.02 HYPOXIA 6/22/2022 ACUTE EXACERBATION OF COPD
Age: 35.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: The vaccine that was given was expired on 2/25/2023.
Age: 0.83
Sex: F
Vaccine: HPV9
Symptoms: Product administered to patient of inappropriate age, Wrong product administered
Clinical narrative: Nurse pulled vaccines to be given to patient after reviewing vaccines that were due. When she pulled them from the fridge she accidentally pulled HPV instead of IPV. Mistake was realized when she was charting vaccines that were given.  Nurse notified NP and state contact person was notified. Mother was called and notified of wrong vaccine given. Mother told to watch for adverse reactions.
Age: 61.0
Sex: F
Vaccine: COVID19-2
Symptoms: Acute respiratory failure, Chronic respiratory failure, Hypoxia, Pulmonary embolism, Respiratory failure
Clinical narrative: ACUTE RESPIRATORY FAILURE ACUTE PULMONARY EMBOLISM CHRONIC HYPOXEMIC RESPIRATORY FAILURE HYPOXIA
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Balance disorder, Dizziness, Tinnitus
Clinical narrative: I did not have an adverse reaction to the vaccine. In 12/2021, I developed a loud noise in my right ear.  It sounds like an electronic chirpy noise. When the noise is loud, I get very dizzy, and I feel like I would fall to the left. The doctors and specialists I have seen have not been able to determine what is going on. I have an appointment on 06/09/2023 with an ENT specialist.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Adult failure to thrive, Anaemia, Deep vein thrombosis
Clinical narrative: ACUTE DVT OF RIGHT LEG, UNSPECIFIED VEIN 6/30/2022 ANEMIA  ACUTE DVT OF RIGHT LEG, UNSPECIFIED VEIN 6/30/2022 FAILURE TO THRIVE SYNDROME, ADULT